vs
Side-by-side financial comparison of Claritev Corp (CTEV) and James River Group Holdings, Inc. (JRVR). Click either name above to swap in a different company.
Claritev Corp is the larger business by last-quarter revenue ($246.6M vs $167.7M, roughly 1.5× James River Group Holdings, Inc.). James River Group Holdings, Inc. runs the higher net margin — 19.1% vs -32.7%, a 51.8% gap on every dollar of revenue. On growth, James River Group Holdings, Inc. posted the faster year-over-year revenue change (32.4% vs 6.2%). Claritev Corp produced more free cash flow last quarter ($36.4M vs $-23.6M). Over the past eight quarters, Claritev Corp's revenue compounded faster (2.5% CAGR vs -8.7%).
James River Corporation was an American pulp and paper company based in Richmond, Virginia, once the largest paper manufacturer in the world.
CTEV vs JRVR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $246.6M | $167.7M |
| Net Profit | $-80.6M | $32.1M |
| Gross Margin | — | — |
| Operating Margin | -3.1% | 14.6% |
| Net Margin | -32.7% | 19.1% |
| Revenue YoY | 6.2% | 32.4% |
| Net Profit YoY | 41.6% | 149.5% |
| EPS (diluted) | $-4.88 | $0.59 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $246.6M | $167.7M | ||
| Q3 25 | $246.0M | $172.7M | ||
| Q2 25 | $241.6M | $174.8M | ||
| Q1 25 | $231.3M | $172.3M | ||
| Q4 24 | $232.1M | $126.7M | ||
| Q3 24 | $230.5M | $191.5M | ||
| Q2 24 | $233.5M | $188.3M | ||
| Q1 24 | $234.5M | $201.1M |
| Q4 25 | $-80.6M | $32.1M | ||
| Q3 25 | $-69.8M | $1.0M | ||
| Q2 25 | $-62.6M | $4.8M | ||
| Q1 25 | $-71.3M | $9.6M | ||
| Q4 24 | $-138.0M | $-64.8M | ||
| Q3 24 | $-391.4M | $-39.4M | ||
| Q2 24 | $-576.7M | $7.6M | ||
| Q1 24 | $-539.7M | $15.4M |
| Q4 25 | -3.1% | 14.6% | ||
| Q3 25 | 4.1% | 1.5% | ||
| Q2 25 | 6.9% | 4.2% | ||
| Q1 25 | 4.2% | 9.3% | ||
| Q4 24 | -17.8% | -57.0% | ||
| Q3 24 | -146.7% | -27.1% | ||
| Q2 24 | -224.4% | 10.7% | ||
| Q1 24 | -207.4% | 16.4% |
| Q4 25 | -32.7% | 19.1% | ||
| Q3 25 | -28.4% | 0.6% | ||
| Q2 25 | -25.9% | 2.7% | ||
| Q1 25 | -30.8% | 5.6% | ||
| Q4 24 | -59.4% | -51.1% | ||
| Q3 24 | -169.8% | -20.6% | ||
| Q2 24 | -247.0% | 4.0% | ||
| Q1 24 | -230.1% | 7.7% |
| Q4 25 | $-4.88 | $0.59 | ||
| Q3 25 | $-4.23 | $-0.02 | ||
| Q2 25 | $-3.81 | $0.06 | ||
| Q1 25 | $-4.38 | $0.16 | ||
| Q4 24 | $-8.49 | $-2.44 | ||
| Q3 24 | $-24.25 | $-1.10 | ||
| Q2 24 | $-35.78 | $0.13 | ||
| Q1 24 | $-33.40 | $0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $16.8M | $260.9M |
| Total DebtLower is stronger | $4.6B | — |
| Stockholders' EquityBook value | $-173.9M | $538.2M |
| Total Assets | $4.9B | $4.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $16.8M | $260.9M | ||
| Q3 25 | $39.2M | $238.8M | ||
| Q2 25 | $56.4M | $220.0M | ||
| Q1 25 | $23.1M | $279.4M | ||
| Q4 24 | $16.8M | $362.3M | ||
| Q3 24 | $86.6M | $359.8M | ||
| Q2 24 | $48.8M | $672.5M | ||
| Q1 24 | $58.7M | $305.5M |
| Q4 25 | $4.6B | — | ||
| Q3 25 | $4.5B | — | ||
| Q2 25 | $4.5B | — | ||
| Q1 25 | $4.5B | — | ||
| Q4 24 | $4.5B | — | ||
| Q3 24 | $4.5B | — | ||
| Q2 24 | $4.5B | — | ||
| Q1 24 | $4.5B | — |
| Q4 25 | $-173.9M | $538.2M | ||
| Q3 25 | $-101.8M | $503.6M | ||
| Q2 25 | $-39.9M | $492.6M | ||
| Q1 25 | $14.8M | $484.5M | ||
| Q4 24 | $84.0M | $460.9M | ||
| Q3 24 | $207.6M | $530.3M | ||
| Q2 24 | $603.4M | $541.8M | ||
| Q1 24 | $1.2B | $539.5M |
| Q4 25 | $4.9B | $4.9B | ||
| Q3 25 | $5.0B | $5.0B | ||
| Q2 25 | $5.1B | $5.0B | ||
| Q1 25 | $5.1B | $4.9B | ||
| Q4 24 | $5.2B | $5.0B | ||
| Q3 24 | $5.3B | $5.0B | ||
| Q2 24 | $5.7B | $4.7B | ||
| Q1 24 | $6.4B | $5.3B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 304.87× | — | ||
| Q4 24 | 53.67× | — | ||
| Q3 24 | 21.73× | — | ||
| Q2 24 | 7.48× | — | ||
| Q1 24 | 3.85× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $66.3M | $-18.8M |
| Free Cash FlowOCF − Capex | $36.4M | $-23.6M |
| FCF MarginFCF / Revenue | 14.8% | -14.1% |
| Capex IntensityCapex / Revenue | 12.1% | 2.9% |
| Cash ConversionOCF / Net Profit | — | -0.59× |
| TTM Free Cash FlowTrailing 4 quarters | $-12.3M | $-17.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $66.3M | $-18.8M | ||
| Q3 25 | $19.9M | $34.3M | ||
| Q2 25 | $61.2M | $25.2M | ||
| Q1 25 | $-30.1M | $-51.5M | ||
| Q4 24 | $-33.4M | $-247.1M | ||
| Q3 24 | $72.8M | $-269.9M | ||
| Q2 24 | $18.5M | $-8.7M | ||
| Q1 24 | $49.7M | $24.1M |
| Q4 25 | $36.4M | $-23.6M | ||
| Q3 25 | $-16.3M | $33.7M | ||
| Q2 25 | $36.6M | $24.7M | ||
| Q1 25 | $-68.9M | $-52.7M | ||
| Q4 24 | $-63.8M | $-252.0M | ||
| Q3 24 | $41.1M | $-270.8M | ||
| Q2 24 | $-7.0M | $-9.3M | ||
| Q1 24 | $19.2M | $23.3M |
| Q4 25 | 14.8% | -14.1% | ||
| Q3 25 | -6.6% | 19.5% | ||
| Q2 25 | 15.2% | 14.1% | ||
| Q1 25 | -29.8% | -30.6% | ||
| Q4 24 | -27.5% | -198.9% | ||
| Q3 24 | 17.8% | -141.4% | ||
| Q2 24 | -3.0% | -4.9% | ||
| Q1 24 | 8.2% | 11.6% |
| Q4 25 | 12.1% | 2.9% | ||
| Q3 25 | 14.7% | 0.4% | ||
| Q2 25 | 10.2% | 0.3% | ||
| Q1 25 | 16.8% | 0.7% | ||
| Q4 24 | 13.1% | 3.9% | ||
| Q3 24 | 13.8% | 0.4% | ||
| Q2 24 | 10.9% | 0.3% | ||
| Q1 24 | 13.0% | 0.4% |
| Q4 25 | — | -0.59× | ||
| Q3 25 | — | 33.61× | ||
| Q2 25 | — | 5.29× | ||
| Q1 25 | — | -5.38× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -1.14× | ||
| Q1 24 | — | 1.56× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTEV
Segment breakdown not available.
JRVR
| Excess And Surplus Lines | $156.7M | 93% |
| Specialty Admitted Insurance | $10.9M | 7% |
